Division News

Velazquez accepts new leadership role at Yale School of Medicine

Eric Velazquez, MD, has been appointed as chief of the Section of Cardiovascular Medicine in the Department of Internal Medicine, Chief of Cardiovascular Medicine at Yale-New Haven Hospital, and Physician-in-Chief of the Heart and Vascular Center for the Yale-New Haven Health System, effective June 4, 2018.

Mining New RNA Science for Clinical Promise

Last year in Christopher Holley’s lab, an uninstalled exhaust hood still wrapped in plastic suggested that the young investigator was just getting going.

Don’t be deceived. Holley arrived a lab-bench veteran when he joined Duke’s cardiology division faculty in 2015. But the physician-scientist is launching something very new: wide-reaching molecular studies into a new field of RNA biology with vast potential.

Pharmacology Studies Fuel a Quest to Shed Drug Side Effects

In clinic, cardiologist Sudarshan Rajagopal, MD, PhD, has no means to cure most patients with pulmonary hypertension, not the narrowing of blood vessels in their lungs, not damage done to their hearts.

The physician-scientist can prescribe medicines that extend the lives of many patients, but the precious gains can come with unwelcome costs.

“All these drugs help open blood vessels in the lungs and help treat heart failure. But they can have horrible side effects,” Rajagopal says, including nausea, diarrhea, weight loss and other side effects.

But help may come from complex pharmacology studies that Rajagopal first encountered at Duke in the laboratory of Nobel Prize winner Robert Lefkowitz, MD.

Eight from Medicine selected for Duke Clinical Leadership Program

Duke Health has announced a new class of the Duke Clinical Leadership Program (DCLP), including eight faculty from the Department of Medicine. The 26 clinicians in the 2018 class will join the ranks of the 169 fellows who completed the DCLP program during its first seven years. 

Department of Medicine celebrates the “Greenfield Era” of Medicine

Joseph Greenfield, MD, chair of the Duke Department of Medicine from 1983 to 1995, is known by many at Duke for the clinical innovations he initiated here. To celebrate Dr. Greenfield and his contributions to the Department and Duke Health, the Department of Medicine will hold a special Medicine Grand Rounds on Friday, Oct. 20, at 8 a.m. in the Great Hall of the Trent Semans Center for Health Education.

Beyond DNA: Probing big data to demystify disease

As a young researcher, Svati Shah expected that genomic studies would reveal vital insights into the roots of disease. When they did not, the cardiologist widened her net to compare many more molecular components at once. The result is a growing understanding of the cellular profile of disease more specific than tales told by static DNA. 

Hernandez named vice dean for clinical research

Dean Mary Klotman, MD, announced that Adrian Hernandez, MD, professor of medicine (Cardiology), will serve as the new vice dean for clinical research for the Duke University School of Medicine.